EDGAR Filing Documents for 0001176256-12-000104

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:

SEC Accession No. 0001176256-12-000104

Filing Date

2012-02-21

Accepted

2012-02-21 14:00:38

Documents

Period of Report

2012-02-21

Document Format Files

Seq	Description	Document	Type	Size
1	REPORT OF FOREIGN ISSUER FOR THE MONTH OF FEBRUARY, 2012	120221nymox6knr.htm	6-K	4894
2	NEWS RELEASE DATE FEBRUARY 21, 2012	exhibit99-1.htm	EX-99.1	7891
3		exhibit99-1x1x1.jpg	GRAPHIC	5004
	Complete submission text file	0001176256-12-000104.txt		20851

Mailing Address 9900 CAVENDISH BLVD., SUITE 306 ST. LAURENT QUEBEC CANADA A8 H4M 2V2

Business Address 9900 CAVENDISH BLVD., SUITE 306 ST. LAURENT QUEBEC CANADA A8 H4M 2V2 5143323222

NYMOX PHARMACEUTICAL CORP (Filer) CIK: 0001018735 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-12033 | Film No.: 12626220
SIC: 2835 In Vitro & In Vivo Diagnostic Substances